During the past decade, U.S. Oncology conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "U.S. Oncology" #1 sponsor was "Genzyme, a Sanofi Company" with 2 trials, followed by "AltaRex" with 1 trials sponsored, "Clovis Oncology, Inc." with 1 trials sponsored, "Eisai Inc." with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "U.S. Oncology" #1 collaborator was "Eisai Limited" with 1 trials as a collaborator, "Sanofi" with 1 trials as a collaborator and "Walther Cancer Institute" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "U.S. Oncology" are "Breast Cancer" (2 trials), "Melanoma (Skin)" (2 trials), "ER" (1 trials), "Endometrial Cancer" (1 trials) and "Estrogen Receptor Positive" (1 trials). Many other conditions were trialed in "U.S. Oncology" in a lesser frequency.

Most popular intervention types in "U.S. Oncology" are "Drug" (4 trials), "Biological" (3 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cisplatin" (1 trials), "Docetaxel" (1 trials), "E7389" (1 trials), "Etoposide" (1 trials) and "Lucitanib" (1 trials). Other intervention names were less common.

The vast majority of trials in "U.S. Oncology" are 4 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "U.S. Oncology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in U.S. Oncology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in U.S. Oncology, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".